106 related articles for article (PubMed ID: 28664246)
1. Babaodan Capsule () combined with Qingyi Huaji Formula () in advanced pancreatic cancer-a feasibility study.
Song LB; Gao S; Zhang AQ; Qian X; Liu LM
Chin J Integr Med; 2017 Dec; 23(12):937-942. PubMed ID: 28664246
[TBL] [Abstract][Full Text] [Related]
2. Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
Ouyang HQ; Liu LM; Chen Z; Luo JM; Yu EX
Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):655-61. PubMed ID: 20619142
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Qingyi Huaji formula for inhibition of pancreatic cancer cell growth through down-regulating Ski expression].
Wang P; Liu LM; Chen Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Sep; 30(9):942-5. PubMed ID: 21179734
[TBL] [Abstract][Full Text] [Related]
4. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
5. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer.
Zhang J; Wang P; Ouyang H; Yin J; Liu A; Ma C; Liu L
PLoS One; 2013; 8(7):e70334. PubMed ID: 23922983
[TBL] [Abstract][Full Text] [Related]
7. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
8. [Effect of qi replenishing and blood circulation activating drugs in treatment of middle-advanced pancreatic cancer with radio- and chemotherapy].
Wang B; Liu X; Wu Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Oct; 20(10):736-8. PubMed ID: 11938807
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Guben Yiliu II combined with arterial perfusion with chemotherapeutic agent in treating advanced pancreatic cancer].
Zhang Q; Wang XM; Chi HC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 May; 27(5):400-3. PubMed ID: 17650790
[TBL] [Abstract][Full Text] [Related]
10. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
Zhou LY; Shan ZZ; You JL
Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
[TBL] [Abstract][Full Text] [Related]
11. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
Xu Y; Xu S; Cai Y; Liu L
Evid Based Complement Alternat Med; 2015; 2015():145016. PubMed ID: 26783407
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy].
Xu ZY; Jin CJ; Shen DY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct; 27(10):874-8. PubMed ID: 17990450
[TBL] [Abstract][Full Text] [Related]
13. High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
Hua YQ; Chen Z; Meng ZQ; Chen H; Shen JG; Wang K; Peng W; Shen YH; Liu LM
Oncol Lett; 2014 Jul; 8(1):17-24. PubMed ID: 24959213
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.
Wu Z; Gabrielson A; Hwang JJ; Pishvaian MJ; Weiner LM; Zhuang T; Ley L; Marshall JL; He AR
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1309-14. PubMed ID: 26507197
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on treatment of advanced stage non-small cell lung cancer by guben xiaoliu capsule].
Wang XM; Xin H; Yang Z; Zhao W; Yang G; Liu J; Tang W; Zhang Q; Han D; Yu R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Nov; 24(11):986-8. PubMed ID: 15609595
[TBL] [Abstract][Full Text] [Related]
16. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ
Complement Ther Med; 2014 Dec; 22(6):1010-8. PubMed ID: 25453521
[TBL] [Abstract][Full Text] [Related]
17. Cardioankle vascular index evaluations revealed that cotreatment of ARB Antihypertension medication with traditional Chinese medicine improved arterial functionality.
Xu Y; Yan H; Yao MJ; Ma J; Jia JM; Ruan FX; Yao ZC; Huang HM; Zheng J; Chen T; Lv H; Endler AM
J Cardiovasc Pharmacol; 2013 May; 61(5):355-60. PubMed ID: 23188130
[TBL] [Abstract][Full Text] [Related]
18. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
[TBL] [Abstract][Full Text] [Related]
19. [Safety and effectiveness of large dose compound Sophora flavescens Ait injection in the treatment of advanced malignant tumors].
Li DR; Lin HS
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):291-4. PubMed ID: 21575502
[TBL] [Abstract][Full Text] [Related]
20. Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.
Wang Z; Liu Y; Li R; Shang Y; Zhang Y; Zhao L; Li W; Yang Y; Zhang X; Yang T; Nie C; Han F; Liu Y; Luo S; Gao Q; Song Y
J Hematol Oncol; 2016 Feb; 9():6. PubMed ID: 26842696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
